SCG Cell Therapy

SCG Cell Therapy is a clinical-stage biotechnology company headquartered in Singapore, with operations spanning Singapore, China, and Germany. The company focuses on developing novel immunotherapies, including T-cell therapies, bispecific antibodies, and therapeutic vaccines, to treat pathogenic infections and their associated cancers, such as Hepatitis B (HBV), Helicobacter pylori, and HPV. By leveraging regional strengths, SCG covers the entire value chain from drug discovery and research to manufacturing, clinical development, and commercialization. The company is particularly noted for its work in TCR-T cell therapies aimed at eradicating persistent viral reservoirs that current antiviral treatments cannot address.